ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
Dow Jones
43,487.83
0.78%
US Dollar vs MXN
20.55054
-1.19%
Brent Oil
78.885
-1.66%
Bitcoin
107,610.92
4.36%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Molecular Partners Ag (0QXX) Cotización

Molecular Partners Ag

Molecular Partners Ag (0QXX)

LSE
25.20
0.00
( 0.00% )
Actualizado: 18:00:00
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
25.20
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
200
0.00 Rango del Día 0.00
25.20 Rango de 52 semanas 25.20
Capitalización de Mercado [m]
916.121M
Precio Anterior
25.20
Precio de Apertura
-
Hora
200
@
4.83
(O)
Última hora de negociación
02:29:06
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
591
Acciones en circulación
36,354,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.65
Beneficio por acción (BPA)
-1.71
turnover
7.04M
Beneficio neto
-61.98M

Acerca de Molecular Partners Ag

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.molecularpartners.com
Sede
Schlieren, Che
Fundado
-
Molecular Partners Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QXX. The last closing price for Molecular Partners was CHF25.20. Over the last year, Molecular Partners shares have traded in a share price range of CHF 25.20 to CHF 25.20.

Molecular Partners currently has 36,354,000 shares in issue. The market capitalisation of Molecular Partners is CHF916.12 million. Molecular Partners has a price to earnings ratio (PE ratio) of -2.65.

0QXX Últimas noticias

Más noticias

Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference

Molecular Partners Outlines Clinical Expansion Plans and Strengthens Radiopharma Strategic Focus for 2025 at 43rd Annual J.P. Morgan Healthcare Conference Radio-DARPin MP0712 against DLL3, in...

12 Enero 2025
UK Regulatory

Molecular Partners and Orano Med expand partnership to develop Targeted Alpha Radio-Therapies for cancer

Molecular Partners and Orano Med expand partnership to develop Targeted Alpha Radio-Therapies for cancer New agreement enables both companies to fuel a broad and innovative pipeline of...

12 Enero 2025
UK Regulatory

Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January

Molecular Partners to Present at JP Morgan Healthcare Conference and Baader Helvea Swiss Equities Conference in January ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Dec. 17, 2024 (GLOBE...

17 Diciembre 2024
UK Regulatory

Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024

Molecular Partners Presents Clinical Data Supporting its Ongoing MP0533 Study and Preclinical Data on Next-Gen Conditioning Agent MP0621 at ASH 2024 MP0533 phase 1/2a dose escalation study...

08 Diciembre 2024
UK Regulatory

Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024

Molecular Partners Presents Preclinical Proof-of-Concept for CD3 Switch-DARPin T Cell Engager, Clinical Biomarker Analyses for MP0317 at SITC 2024 Preclinical proof-of-concept data supports the...

07 Noviembre 2024
UK Regulatory

Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition

Molecular Partners Announces Upcoming Poster Presentations at the 65th ASH Annual Meeting and Exposition Clinical update from ongoing MP0533 phase 1/2a dose escalation study confirms overall...

05 Noviembre 2024
UK Regulatory

Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going

Molecular Partners Q3 2024 Interim Management Statement: Multiple Updates Across Portfolio, Radio-DARPin candidate MP0712 preparing for clinical entry, MP0533 Phase 1 on-going Radio-DARPin Therapy...

31 Octubre 2024
UK Regulatory

Molecular Partners Announces Pricing of $20 Million Underwritten Offering

Molecular Partners Announces Pricing of $20 Million Underwritten Offering ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art...

25 Octubre 2024
UK Regulatory

Molecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics

Molecular Partners and Orano Med Strengthen Agreement to Co-Develop 212Pb-Based Radio-DARPin Therapeutics Under the revised agreement, both companies will co-develop four Radio-DARPin programs;...

22 Octubre 2024
UK Regulatory

Molecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024

Molecular Partners and Orano Med Present Additional Positive Preclinical Data Supporting DLL3 Targeting Radio-DARPin Therapeutic Candidate MP0712 at EANM 2024 Dose-dependent efficacy observed with...

22 Octubre 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10025.225.225.2113925.2DE
40025.225.225.250325.2DE
120025.225.225.259125.2DE
260025.225.225.239125.2DE
520025.225.225.235625.2DE
1560025.225.225.2614625.2DE
2600025.225.225.2517625.2DE

0QXX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Molecular Partners?
El precio actual de las acciones de Molecular Partners es CHF 25.20
¿Cuántas acciones de Molecular Partners están en circulación?
Molecular Partners tiene 36,354,000 acciones en circulación
¿Cuál es la capitalización de mercado de Molecular Partners?
La capitalización de mercado de Molecular Partners es CHF 916.12M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Molecular Partners?
Molecular Partners ha negociado en un rango de CHF 25.20 a CHF 25.20 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Molecular Partners?
El ratio precio/beneficio de Molecular Partners es -2.65
¿Cuál es el ratio de efectivo a ventas de Molecular Partners?
El ratio de efectivo a ventas de Molecular Partners es 23.3
¿Cuál es la moneda de reporte de Molecular Partners?
Molecular Partners presenta sus resultados financieros en CHF
¿Cuál es el último ingresos anual de Molecular Partners?
El último ingresos anual de Molecular Partners es CHF 7.04M
¿Cuál es el último beneficio anual de Molecular Partners?
El último beneficio anual de Molecular Partners es CHF -61.98M
¿Cuál es la dirección registrada de Molecular Partners?
La dirección registrada de Molecular Partners es WAGISTRASSE 14, SCHLIEREN, 8952
¿Cuál es la dirección del sitio web de Molecular Partners?
La dirección del sitio web de Molecular Partners es www.molecularpartners.com
¿En qué sector industrial opera Molecular Partners?
Molecular Partners opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BLUBlue Star Capital Plc
12.00p
(45.45%)
1.15M
NTQEnteq Technologies Plc
1.45p
(45.00%)
18.86M
BANKFiinu Plc
10.25p
(36.67%)
5.39M
TIRTiger Royalties And Investments Plc
0.17p
(36.00%)
133.06M
TRLSTrellus Health Plc
3.10p
(29.17%)
11.58M
PODPPod Point Group Holdings Plc
10.50p
(-37.46%)
5.71M
PALMPanther Metals Plc
52.50p
(-36.36%)
216.84k
NOGNostrum Oil & Gas Plc
2.51p
(-23.82%)
117.55k
ADMEAdm Energy Plc
0.175p
(-22.22%)
991.32k
PRDPredator Oil & Gas Holdings Plc
5.85p
(-20.95%)
5.22M
NTVONativo Resources Plc
0.002p
(5.26%)
721.2M
TRPTower Resources Plc
0.0315p
(1.61%)
411.59M
PREMPremier African Minerals Limited
0.027p
(-3.57%)
409.41M
SYMESupply@me Capital Plc
0.0035p
(1.45%)
344.42M
TYMTertiary Minerals Plc
0.075p
(7.14%)
243.98M

Discusión

Ver feed completo
waterchaser waterchaser 4 minutos hace
CANB = Money lost.

https://investorshub.advfn.com/uimage/uploads/2018/3/20/picfxToilet_.png
CANB
Bubae Bubae 4 minutos hace
Aside from the debt to be converted detailed in the reg A offering, we also have several new convertible notes in December. Wait, didn't the company just last Tuesday say that they settled all outstanding convertible debt? What they mean is that they have agreements to convert it with the offering.
RDAR
peafunke peafunke 5 minutos hace
https://www.theverge.com/2025/1/19/24347463/trump-plan-to-save-tiktok-from-ban

" style="caret-color: rgb(0, 0, 0); color: rgba(0, 0, 0, 1); font-family: __fkRomanStandard_6bdc6d, __fkRomanStan
TPTW
RMS555 RMS555 5 minutos hace
now we can finally get back to NNRX: 🖕Jonathan Bishop and Your Pumpers!!!


.
NNRX
budfoxfun budfoxfun 6 minutos hace
Restoring the balance of nature while promoting responsible consumption. https://thesustainablegreenteam.com/sgtm-blog
SGTM
StockItOut StockItOut 6 minutos hace
You're an expert at misstatements, half-truths, and outright lies, when in every single post you pump Xeriant.

Fact.
XERI
peanutz peanutz 6 minutos hace
3 executive orders on drilling alone signed later today . AZRH will begin to recover some of the PPS lost . From drillers to suppliers to storage is about to get busy !
AZRH
RMS555 RMS555 7 minutos hace
its so nice to see the pumpers of this SCAM stock start arguing with each other! Thanks for being semi-real BeachBum (finally)!

In the meantime; PSRU IS A SCAM ...... Xavier Mitchell is a WANNABE!!!!!


.
PSRU
m0n m0n 7 minutos hace
I Believe This Helps $TWOH

https://www.sec.gov/edgar/browse/?CIK=0001494413


and $TWOH

TWOH
Zardiw Zardiw 8 minutos hace
It could have easily happened......after all they (libtards) managed to burn down half of LA right?.......and got Trump a felony conviction on a book keeping error........lol....and killed over 100,000 Palestinians..........and over 1M ukrainians........and on the verge of nuclear war with Russia...
TrendTrade2016 TrendTrade2016 8 minutos hace
YOUR ONLY STOCK HAS NOT MOVED SINCE YOUR FAILED ATTEMPTS AT PUMPING IT
getmoreshares getmoreshares 8 minutos hace
went above 109K !!!
https://pbs.twimg.com/media/GhvN8FSWkAEvNBA?format=jpg&name=small
CGAC
pos_stock_hoarder pos_stock_hoarder 9 minutos hace
It's how our kids see us. Like you, I'm not talking to machines except my telephone! And that's actually talking THROUGH the machine!
Jake731 Jake731 9 minutos hace
GOOD MORNING ALL.










TPTW……!!!!!!!
TPTW
Zardiw Zardiw 9 minutos hace
Quick Summary of $TORVF:

1. Their CEO is a mini version of Elon Musk

2. They have massive Graphite mining claims, which are 8x purer than anywhere else.

3. Their Air Qualifier for Graphite is a technological revolution in Graphite Production.
And
TORVF
getmoreshares getmoreshares 10 minutos hace
https://pbs.twimg.com/media/GhvN8FSWkAEvNBA?format=jpg&name=small
Zardiw Zardiw 10 minutos hace
Biggest example of libtard incompetence there is............

Z
Nogobeaver Nogobeaver 10 minutos hace
I am simply telling the true side of the story that is neglected to be told here and elswere

If you cant handel it get step aside and get someone in charge who has the skills to turn this around. Unfortinatly its too late for that you blew your chance
SGTM

Su Consulta Reciente

LSE
0QXX
Molecular Partners
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados